1-4 of 4
A Tompkins
Close
Sort by
Journal Articles

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial

Clinical Trials & Observations
A. Keith Stewart, Suzanne Trudel, Nizar J. Bahlis, Darrell White, Waleed Sabry, Andrew Belch, Tony Reiman, Jean Roy, Chaim Shustik, Michael J. Kovacs, Morel Rubinger, Guy Cantin, Kevin Song, Kirsty A. Tompkins, Deb C. Marcellus, Martha Q. Lacy, Jonathan Sussman, Donna Reece, Michael Brundage, Erica L. Harnett, Lois Shepherd, Judy-Anne W. Chapman, Ralph M. Meyer
Journal: Blood
Blood (2013) 121 (9): 1517–1523.
https://doi.org/10.1182/blood-2012-09-451872
Published: 2013
Journal Articles

Predicting Risk of Febrile Neutropenia after CHOP Chemotherapy.

Ramandeep K. Chawla, MBBS, Kirsty A. Tompkins, MD, Mark R. Borgaonkar, MD, Peter R. Duggan, MD
Journal: Blood
Blood (2004) 104 (11): 4585.
https://doi.org/10.1182/blood.V104.11.4585.4585
Published: 2004
Journal Articles

Pseudomembranous Colitis Following Autologous Stem Cell Transplantation.

Joanne M. Hickey, BSc MD, Kirsty A. Tompkins, MD FRCPC, Peter R. Duggan, MD FRCPC
Journal: Blood
Blood (2004) 104 (11): 5071.
https://doi.org/10.1182/blood.V104.11.5071.5071
Published: 2004
Journal Articles

Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study

FM Foss, TA Borkowski, M Gilliom, M Stetler-Stevenson, ES Jaffe, WD Figg, A Tompkins, A Bastian, P Nylen, T Woodworth
Journal: Blood
Blood (1994) 84 (6): 1765–1774.
https://doi.org/10.1182/blood.V84.6.1765.1765
Published: 1994